Bucillamine in Treatment of Patients With COVID-19
Clinical trial NCT04504734 · TERMINATED
Trial details
- NCT number
- NCT04504734
- Sponsor
- Revive Therapeutics, Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2023-06-12
- Enrollment
- 713
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.